1. INTRODUCTION
1.1. MARKET OVERVIEW
1.2. MARKET DEFINITION
1.3. SCOPE OF THE STUDY
1.4. CURRENCY
1.5. ASSUMPTIONS
1.6. BASE, AND FORECAST YEARS TIMELINE
2. RESEARCH METHODOLOGY
2.1. RESEARCH DESIGN
2.2. SECONDARY SOURCES
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. MARKET SEGMENTATION
4.2. MARKET DRIVERS
4.3. MARKET RESTRAINTS
4.4. MARKET OPPORTUNITIES
4.5. PORTER’S FIVE FORCE ANALYSIS
4.5.1. BARGAINING POWER OF SUPPLIERS
4.5.2. BARGAINING POWER OF BUYERS
4.5.3. THREAT OF NEW ENTRANTS
4.5.4. THREAT OF SUBSTITUTES
4.5.5. COMPETITIVE RIVALRY IN THE INDUSTRY
4.6. LIFE CYCLE ANALYSIS - REGIONAL SNAPSHOT
4.7. MARKET ATTRACTIVENESS
5. MICROBIAL LIPASE MARKET BY APPLICATION
5.1. DAIRY PRODUCTS
5.2. BAKERY PRODUCTS
5.3. CONFECTIONERY PRODUCTS
5.4. ANIMAL FEED
5.5. CLEANING AGENT
5.6. OTHERS
6. MICROBIAL LIPASE MARKET BY FORM
6.1. POWDER
6.2. LIQUID
7. MICROBIAL LIPASE MARKET BY SOURCE
7.1. FUNGI
7.2. BACTERIA
8. MICROBIAL LIPASE MARKET BY GEOGRAPHY
8.1. NORTH AMERICA
8.1.1. USA
8.1.2. CANADA
8.1.3. MEXICO
8.2. SOUTH AMERICA
8.2.1. BRAZIL
8.2.2. ARGENTINA
8.2.3. OTHERS
8.3. EUROPE
8.3.1. GERMANY
8.3.2. FRANCE
8.3.3. UNITED KINGDOM
8.3.4. SPAIN
8.3.5. OTHERS
8.4. MIDDLE EAST AND AFRICA
8.4.1. SAUDI ARABIA
8.4.2. ISRAEL
8.4.3. OTHERS
8.5. ASIA PACIFIC
8.5.1. CHINA
8.5.2. JAPAN
8.5.3. SOUTH KOREA
8.5.4. INDIA
8.5.5. OTHERS
9. COMPETITIVE INTELLIGENCE
9.1. COMPANY BENCHMARKING AND ANALYSIS
9.2. RECENT INVESTMENT AND DEALS
9.3. STRATEGIES OF KEY PLAYERS
10. COMPANY PROFILES
10.1. NOVOZYMES
10.2. DSM
10.3. CHR. HANSEN
10.4. AMANO ENZYMES
10.5. ASSOCIATED BRITISH FOODS
10.6. DUPONT
10.7. ADVANCED ENZYMES
10.8. ENZYME DEVELOPMENT CORPORATION
10.9. AUMGENE BIOSCIENCES
10.10. BIOCATALYST
LIST OF FIGURES
LIST OF TABLES